Clinical Trial Update: The Effect of Rasagiline on Cognition in Parkinson's Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the effect of rasagiline on cognition in Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• RASAGILINE (rasagiline)

Snippet

Sponsor: Brown University | Conditions: Parkinson's Disease | Phase 4 | Status: COMPLETED